---
title: "NHS National Pharmaceuticals -- Fulvestrant, Darunavir and Imatinib"
ocid: "ocds-h6vhtk-029839"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029839"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-029839.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-029839.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)"
published: "2021-03-04"
---

# NHS National Pharmaceuticals -- Fulvestrant, Darunavir and Imatinib

Buyer: THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)  
Current stage: Award  
OCID: ocds-h6vhtk-029839

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029839)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-029839.json)

## Summary

The procurement process involves the NHS Commissioning Board, operating as NHS England, seeking suppliers for pharmaceutical products under the title "NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib." This tender was initiated through an open procedure and has already reached the award stage, with key dates indicating potential product call-offs commencing as soon as possible and ending by October 31, 2021. The procurement falls within the goods category and is classified under the CPV code 33600000, indicating its focus on pharmaceuticals.

This tender presents an excellent opportunity for businesses in the pharmaceutical sector, particularly those offering products similar to Fulvestrant, Darunavir, and Imatinib. Companies of various sizes, ranging from large-scale suppliers to small and medium enterprises (SMEs), can compete effectively, especially those capable of providing the required goods within the specified timelines. The flexibility of a framework agreement allows for extended partnerships, enhancing the long-term growth potential for successful bidders in a critical healthcare market.

## Notice

Project title: invitation to offer for NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021.

### Lot Information

Lot 1

Project title: invitation to offer for NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/004316-2021 |
| Notice type | Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 4 Mar 2021 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 15 Jan 2021 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £1 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND) |
| Locality | RUNCORN |
| Post town | Warrington |
| Postcode | WA7 2ES |
| Country | England |
| ITL 1 | TLD North West (England) |
| ITL 2 | TLD7 Merseyside |
| ITL 3 | TLD71 East Merseyside |
| Local authority | Halton |
| Electoral ward | Halton Lea |
| Westminster constituency | Runcorn and Helsby |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 10 |
| Supplier names | ACCORD-UK; ASTRAZENECA; CIPLA (EU; DR.REDDY'S LABORATORIES (UK; JANSSEN-CILAG; NOVARTIS PHARMACEUTICALS; SANDOZ; TEVA; THORNTON AND ROSS; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 4 Mar 2021 at 10:27 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/004316-2021

## Notice URLs

- https://ted.europa.eu/udl?uri=TED:NOTICE:562997-2020:TEXT:EN:HTML
- https://www.england.nhs.uk/
- https://www.gov.uk/courts-tribunals

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029839. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-029839.json.